Suppr超能文献

单细胞离子流表型分析阐明了自动化药物实验过程中心肌细胞的非经典特征和预测潜力。

Single-cell ionic current phenotyping elucidates non-canonical features and predictive potential of cardiomyocytes during automated drug experiments.

机构信息

Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Department of Physiology and Pharmacology, SUNY Downstate Health Sciences University, Brooklyn, New York, USA.

出版信息

J Physiol. 2024 Oct;602(20):5163-5178. doi: 10.1113/JP285120. Epub 2024 May 15.

Abstract

All new drugs must go through preclinical screening tests to determine their proarrhythmic potential. While these assays effectively filter out dangerous drugs, they are too conservative, often misclassifying safe compounds as proarrhythmic. In this study, we attempt to address this shortcoming with a novel, medium-throughput drug-screening approach: we use an automated patch-clamp system to acquire optimized voltage clamp (VC) and action potential (AP) data from human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) at several drug concentrations (baseline, 3×, 10× and 20× the effective free plasma concentrations). With our novel method, we show correlations between I block and upstroke slowing after treatment with flecainide or quinine. Additionally, after quinine treatment, we identify significant reductions in current during voltage steps designed to isolate I and I. However, we do not detect any I block by either drug, and upon further investigation, do not see any I present in the iPSC-CMs when prepared for automated patch experiments (i.e. in suspension) - this is in contrast to similar experiments we have conducted with these cells using the manual patch setup. In this study, we: (1) present a proof-of-concept demonstration of a single-cell medium-throughput drug study, and (2) characterize the non-canonical electrophysiology of iPSC-CMs when prepared for experiments in a medium-throughput setting. KEY POINTS: Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offer potential as an in vitro model to study the proarrhythmic potential of drugs, but insights from these cells are often limited by the low throughput of manual patch-clamp. In this study, we use a medium-throughput automated patch-clamp system to acquire action potential (AP) and complex voltage clamp (VC) data from single iPSC-CMs at multiple drug concentrations. A correlation between AP upstroke and I transients was identified and drug-induced changes in ionic currents found. We also characterize the substantially altered physiology of iPSC-CMs when patched in an automated system, suggesting the need to investigate differences between manual and automated patch experiments.

摘要

所有新药都必须经过临床前筛选试验,以确定其致心律失常的潜力。虽然这些检测有效地筛选出了危险药物,但它们过于保守,往往将安全化合物错误地归类为致心律失常。在这项研究中,我们试图通过一种新颖的、高通量的药物筛选方法来解决这一缺点:我们使用自动化膜片钳系统从人诱导多能干细胞衍生的心肌细胞(iPSC-CMs)在几个药物浓度(基线、3×、10×和 20×有效游离血浆浓度)下获取优化的电压钳(VC)和动作电位(AP)数据。使用我们的新方法,我们显示了在用氟卡尼或奎宁处理后 I 阻断和上升斜率减慢之间的相关性。此外,在用奎宁处理后,我们发现电流在设计用于分离 I 和 I 的电压步中显著降低。然而,我们没有检测到任何一种药物的 I 阻断,进一步研究发现,当为自动化膜片实验(即在悬浮液中)准备 iPSC-CMs 时,没有任何 I 存在 - 这与我们使用手动膜片钳设置进行的类似实验形成对比。在这项研究中,我们:(1)展示了一种单细胞高通量药物研究的概念验证演示,(2)描述了当在高通量设置下进行实验时 iPSC-CMs 的非典型电生理特性。关键点:人诱导多能干细胞衍生的心肌细胞(iPSC-CMs)为研究药物的致心律失常潜力提供了一种体外模型,但这些细胞的见解往往受到手动膜片钳低通量的限制。在这项研究中,我们使用高通量自动化膜片钳系统从多个药物浓度的单个 iPSC-CMs 中获取动作电位(AP)和复杂电压钳(VC)数据。确定了 AP 上升和 I 瞬变之间的相关性,并发现了药物诱导的离子电流变化。我们还描述了当在自动化系统中进行膜片钳时 iPSC-CMs 的生理学发生了重大改变,这表明需要研究手动和自动化膜片钳实验之间的差异。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验